Back to KI Korea Investment CORP

ALXNALXN
12 quarters

Position history for KIKorea Investment CORP's holdings in ALEXION PHARMACEUTICALS INC

As of its Q2 2021 13F, Korea Investment held 45,500 shares of ALXN (Alexion Pharmaceuticals), worth $8.4M. Korea Investment's 13F filings listed ALXN from Q4 2018 to Q2 2021, 11 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$14.5M

Total Shares Change

-149,002

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2021-Q3
Latest
Exited
0
-100.0%
$00.0%—
0
2021-Q2
Decreased
45,500
-52.2%
$8.4M0.0%—
0
2021-Q1
Increased
95,200
+51.1%
$14.6M0.0%—
39
2020-Q4
Decreased
63,000
-51.8%
$9.8M0.0%—
0
2020-Q3
Decreased
130,791
-14.6%
$15M0.1%—
0
2020-Q2
Decreased
153,192
-31.8%
$17.2M0.1%—
0
2020-Q1
Increased
224,492
+7.5%
$20.2M0.1%—
31
2019-Q4
Increased
208,792
+14.0%
$22.6M0.1%—
32
2019-Q3
Decreased
183,192
-7.2%
$17.9M0.1%—
0
2019-Q2
Decreased
197,392
-4.6%
$25.9M0.1%—
0
2019-Q1
Increased
206,892
+38.9%
$28M0.1%—
45
2018-Q4
First report
149,002
-
$14.5M0.1%—
0

Other major holders of ALXN: FMR LLC, STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used